✦ LIBER ✦

The efficacy and safety of abatacept in patients with non–life-threatening manifestations of systemic lupus erythematosus: Results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial

✍ Scribed by J. T. Merrill; R. Burgos-Vargas; R. Westhovens; A. Chalmers; D. D'Cruz; D. J. Wallace; S. C. Bae; L. Sigal; J.-C. Becker; S. Kelly; K. Raghupathi; T. Li; Y. Peng; M. Kinaszczuk; P. Nash

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 222 KB
Volume: 62
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.27601

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Abatacept in the treatment of patients w

Abatacept in the treatment of patients with psoriatic arthritis: Results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial

✍ Philip Mease; Mark C. Genovese; Geoffrey Gladstein; Alan J. Kivitz; Christopher 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 1 views

Treatment of rheumatoid arthritis with t

Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: Twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial

✍ Joel M. Kremer; Maxime Dougados; Paul Emery; Patrick Durez; Jean Sibilia; Willia 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

Treatment of rheumatoid arthritis with t

Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: Twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial

✍ Joel M. Kremer; Maxime Dougados; Paul Emery; Patrick Durez; Jean Sibilia; Willia 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

## Abstract ## Objective To determine the clinical efficacy, safety, and immunogenicity of abatacept (CTLA‐4Ig), a selective costimulation modulator, in patients with rheumatoid arthritis (RA) that has remained active despite methotrexate (MTX) therapy. ## Methods This was a 12‐month, multicente

The efficacy and safety of rituximab in

The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial

✍ Paul Emery; Roy Fleischmann; Anna Filipowicz-Sosnowska; Joy Schechtman; Leszek S 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 2 views

Evaluation of the efficacy and safety of

Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: Results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

✍ Oliver Distler; Wolfgang Eich; Eva Dokoupilova; Zdenek Dvorak; Martin Fleck; Mar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

Comparison of the clinical efficacy and

Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: Results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial

✍ J. Braun; P. Kästner; P. Flaxenberg; J. Währisch; P. Hanke; W. Demary; U. von Hi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB 👁 2 views